IOF News

February 10, 2016
children drinking milk
The National Osteoporosis Foundation (NOF) has published a position statement providing evidence-based guidance and a national implementation strategy to help children and adolescents achieve optimal "peak bone mass" early in life.
February 4, 2016
Despite the severity and prevalence of osteoporosis, a new survey from Osteoporosis Canada reveals startling gaps in Canadians' knowledge and understanding of the disease.
January 28, 2016
man reading Osteoporosis International journal
Which were last year’s most downloaded papers in the journals 'Osteoporosis International', 'Calcified Tissue International & Musculoskeletal Research' and 'Archives of Osteoporosis'? Find out - and sign up to access these important publications.
January 25, 2016
New IOF Board members in 2016
IOF’s international Board welcomes five new members from North America, Europe, Middle East & North Africa and Latin America; Appreciation and thanks extended to departing IOF Board members.
January 21, 2016
The approximate 30% increase in the number of abstracts submitted attests to the growing importance of this key annual Congress as a forum of choice for the presentation of clinical research in the musculoskeletal field.
January 14, 2016
Friday January 15, 2016 is the deadline for abstract submissions to the field'd leading annual Congress. All accepted abstracts will be published in Osteoporosis International.
January 11, 2016
free slide set of key research highlights from the ASBMR 2015
Download slides sets of selected hot new research based on the abstracts presented at the ASBMR 2015, the Annual Meeting of the American Society for Bone and Mineral Research.
January 8, 2016
NCD Café session at the World Diabetes Congress 2015
IOF, member of the NCDA Supporters Consultation Group, was represented by CSA member Prof. David Kendler at a session held in conjunction with the World Diabetes Congress 2015.
January 5, 2016
patient sits with doctor
Editorial considera que los beneficios de la terapia continua en pacientes de alto riesgo supera, en gran medida, el riesgo de efectos adversos poco comunes; insta a los médicos a individualizar las decisiones de tratamiento de acuerdo al riesgo de fractura del paciente.
January 4, 2016
patient sits with doctor
Editorial finds that the benefits of continuing therapy in high risk patients greatly exceeds the risk of rare side effects; calls on doctors to individualize treatment decisions based on a patient’s fracture risk.

Pages